Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-03-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75003), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA CROIX DE MALTE : revenue, balance sheet and financial ratios
PHARMACIE DE LA CROIX DE MALTE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75003),
this company of category PME
shows in 2020 a net income positive of 28 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA CROIX DE MALTE (SIREN 494945793)
Indicator
2020
2019
2017
2016
Revenue
N/C
N/C
N/C
N/C
Net income
28 423 €
7 307 €
74 653 €
37 262 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2020, PHARMACIE DE LA CROIX DE MALTE generates positive net income of 28 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 37 k€ -> 28 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
28 423 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 101%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
100.874%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.701%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA CROIX DE MALTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
Debt ratio
160.639
127.661
100.359
100.874
Financial autonomy
33.671
37.76
42.319
41.701
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
100.872020
2017
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average
In 2020, the debt ratio of PHARMACIE DE LA CROIX DE ... (100.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.7%2020
2017
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Good
In 2020, the financial autonomy of PHARMACIE DE LA CROIX DE ... (41.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 135.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
135.173
Liquidity indicators evolution PHARMACIE DE LA CROIX DE MALTE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2020
Liquidity ratio
161.586
151.811
118.355
135.173
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
135.172020
2017
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Average-21 pts over 3 years
In 2020, the liquidity ratio of PHARMACIE DE LA CROIX DE ... (135.17) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE LA CROIX DE MALTE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of PHARMACIE DE LA CROIX DE MALTE is estimated at
401 692 €
(range 267 842€ - 541 991€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
267k€401k€541k€
401 692 €Range: 267 842€ - 541 991€
NAF 5 année 2020
Valuation method used
Net Income Multiple
28 423 €
×
14.1x
=401 693 €
Range: 267 843€ - 541 992€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA CROIX DE MALTE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA CROIX DE MALTE
What is the revenue of PHARMACIE DE LA CROIX DE MALTE ?
The revenue of PHARMACIE DE LA CROIX DE MALTE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA CROIX DE MALTE profitable?
Yes, PHARMACIE DE LA CROIX DE MALTE generated a net profit of 28 k€ in 2020.
Where is the headquarters of PHARMACIE DE LA CROIX DE MALTE ?
The headquarters of PHARMACIE DE LA CROIX DE MALTE is located in PARIS (75003), in the department Paris.
Where to find the tax return of PHARMACIE DE LA CROIX DE MALTE ?
The tax return of PHARMACIE DE LA CROIX DE MALTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA CROIX DE MALTE operate?
PHARMACIE DE LA CROIX DE MALTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart